Lightening the Load: Generative AI to Mitigate the Burden of the New Era of Obesity Medical Therapy
AbstractHighly effective antiobesity and diabetes medications such as glucagon-like peptide 1 (GLP-1) agonists and glucose-dependent insulinotropic polypeptide/GLP-1 (dual) receptor agonists (RAs) have ushered in a new era of treatment of these highly prevalent, morbid conditions that hav...
| Published in: | JMIR Diabetes |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2024-11-01
|
| Online Access: | https://diabetes.jmir.org/2024/1/e58680 |